Synaffix
Presence
Lonza is one of the...
Lonza is a company listed under the stock ticker LONN (CH).
Lonza has a direct presence in 2 countries.
They are in:
- Biotechnology50%
- Pharmaceuticals50%
Executives
View the org chart displaying its 6 main executives
Most searched biographies at Synaffix
- Peter van de Sande, Chief Executive Officer
- Ulrich Osswald, Director
- Anthony DeBoer, Vice President, Business Development
Popular executive movements at Lonza
- Jean-Marc Huët has joined the company as Chairman of the Board (posted on May 12 2024).
- Wolfgang Wienand will join the company as Chief Executive Officer in Jun. 2024 (posted on April 3 2024).
- Albert Baehny who is Chairman of the Board and Interim Chief Executive Officer, will become Interim Chief Executive Officer in Apr. 2024 (posted on January 26 2024).
Click here to view some more movements at Lonza
Create your alert
to follow the executive moves at Synaffix.
Pharmaceuticals
Lonza has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Synaffix
- News – Synaffix
- News – Page 5 – Synaffix
- News – Page 3 – Synaffix
- News – Page 2 – Synaffix
- News – Page 4 – Synaffix
Social media about Synaffix
- Synaffix on Wikipedia, Google News & Yahoo Finance
- Synaffix on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Peter van de Sande 
